| 書目名稱 | Tumor Prevention and Genetics |
| 編輯 | Hans-J?rg Senn,Rudolf Morant |
| 視頻video | http://file.papertrans.cn/931/930822/930822.mp4 |
| 叢書名稱 | Recent Results in Cancer Research |
| 圖書封面 |  |
| 描述 | Hans-Jorg Senn H.-J. Senn (~) Center for Tumor Detection and Prevention, Rorschacherstr. 150, CH-9006 St. Gallen, Switzerland Clinical oncology has centered mainly on developing new strategies and a multitude of new drugs for fighting relapsing and progressive cancer during the last two decades. Furthermore, it has done this with respectable success in quite a number of neoplastic diseases such as acute leukemias and sarcomas in pediatric patients and certain types of aggressive lymphomas, as well as se- lected solid tumors such as testicular cancer and choriocarcinoma in adult age. Curatively intended adjuvant chemo-and endocrine-therapies of several "main killers" among prevalent cancer types, especially breast and colon can- cer, have also become successful and health-politically meaningful therapeutic targets [1, 2]. However, the net gain in "cure" of these (mostly pharmacologic) therapeu- tic approaches has to be realistically judged as having a moderate impact on the cancer problem as a whole, and the mortality rate of the most frequent tu- mor types, which are prevalent in adult life, has with very few exceptions not been substantially decreased over the past two to three de |
| 出版日期 | Conference proceedings 2003 |
| 關(guān)鍵詞 | Cancer Screening; Cancer prevention; breast cancer; cancer genetics; cancer screnning; chemoprevention; ge |
| 版次 | 1 |
| doi | https://doi.org/10.1007/978-3-642-55647-0 |
| isbn_softcover | 978-3-642-62892-4 |
| isbn_ebook | 978-3-642-55647-0Series ISSN 0080-0015 Series E-ISSN 2197-6767 |
| issn_series | 0080-0015 |
| copyright | Springer-Verlag Berlin Heidelberg 2003 |
|Archiver|手機版|小黑屋|
派博傳思國際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-25 15:41
發(fā)表于 2025-3-21 18:56:59
